Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Alteration in Levels of Specific miRNAs and Their Potential Protein Targets between Human Pancreatic Cancer Samples, Adjacent Normal Tissue, and Xenografts Derived from These Tumors.
Journal: Life (Basel, Switzerland)
Published: December 09, 2022
Efficacy and toxicity of primary re-irradiation for malignant spinal cord compression based on radiobiological modelling: a phase II clinical trial.
Journal: British journal of cancer
Published: June 22, 2022
Rett Syndrome and Fragile X Syndrome: Different Etiology With Common Molecular Dysfunctions.
Journal: Frontiers in cellular neuroscience
Published: August 25, 2021
Proteomic Analysis of Cell Lines and Primary Tumors in Pancreatic Cancer Identifies Proteins Expressed Only In Vitro and Only In Vivo.
Journal: Pancreas
Published: August 25, 2020
Proteomic analysis of pancreatic ductal adenocarcinoma.
Journal: Expert review of proteomics
Published: August 07, 2020
Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients.
Journal: International journal of molecular sciences
Published: December 13, 2019
Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compression.
Journal: British journal of cancer
Published: January 22, 2019
A Comparative Quantitative LC-MS/MS Profiling Analysis of Human Pancreatic Adenocarcinoma, Adjacent-Normal Tissue, and Patient-Derived Tumour Xenografts.
Journal: Proteomes
Published: October 16, 2018
(ICORG 05-03): prospective randomized non-inferiority phase III trial comparing two radiation schedules in malignant spinal cord compression (not proceeding with surgical decompression); the quality of life analysis.
Journal: Acta oncologica (Stockholm, Sweden)
Published: February 09, 2018
A novel inhibitory anti-invasive MAb isolated using phenotypic screening highlights AnxA6 as a functionally relevant target protein in pancreatic cancer.
Journal: British journal of cancer
Published: June 09, 2017
Proteomic strategies in the search for novel pancreatic cancer biomarkers and drug targets: recent advances and clinical impact.
Journal: Expert review of proteomics
Published: March 18, 2016
Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in tumour tissue and blood samples from patients diagnosed with lung cancer.
Journal: Molecular bioSystems
Published: December 09, 2014
Last Updated: 09/26/2026